UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 334

Sortiert nach

The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification

Leukemia, 2024-02, Vol.38 (2), p.442-445

2024

Link zum Volltext

Verfügbarkeit prüfen

Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias

Leukemia research, 2014-12, Vol.38 (12), p.1413-1419

2014

Link zum Volltext

Verfügbarkeit prüfen

Assessing in vitro dermal absorption of dry residues of agrochemical sprays using human skin within OECD TG 428

Regulatory toxicology and pharmacology, 2019-08, Vol.106, p.55-67

2019

Link zum Volltext

Verfügbarkeit prüfen

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

Blood, 2004-09, Vol.104 (5), p.1266-1269

2004

Link zum Volltext

Verfügbarkeit prüfen

Who Classification 2016 for the Myelodysplastic Syndromes (MDS): Main Changes

Leukemia research, 2017-04, Vol.55, p.S77-S77

2017

Link zum Volltext

Verfügbarkeit prüfen

Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML

Leukemia research, 2018-02, Vol.65, p.1-4

2018

Link zum Volltext

Verfügbarkeit prüfen

Assessment of in vitro human dermal absorption studies on pesticides to determine default values, opportunities for read-across and influence of dilution on absorption

Regulatory toxicology and pharmacology, 2014-04, Vol.68 (3), p.412-423

2014

Link zum Volltext

Verfügbarkeit prüfen

Thalidomide for the treatment of patients with myelodysplastic syndromes

Leukemia, 2002, Vol.16 (1), p.1-6

2002

Link zum Volltext

Verfügbarkeit prüfen

P772: PROGNOSTIC IMPACT OF DISEASE‐RELATED RISK FACTORS AND TREATMENT APPROACHES IN PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROMES (MDS)

HemaSphere, 2022-06, Vol.6, p.667-668

2022

Link zum Volltext

Verfügbarkeit prüfen

I-005 WHO 2013

Leukemia research, 2013-05, Vol.37, p.S2-S2

2013

Link zum Volltext

Verfügbarkeit prüfen

Transfusion Need and Comorbidities are Independent Prognostic Parameters in Low Risk MDS Patients

Leukemia research, 2017-04, Vol.55, p.S148-S148

2017

Link zum Volltext

Verfügbarkeit prüfen

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)

Leukemia, 2005-12, Vol.19 (12), p.2223-2231

2005

Link zum Volltext

Verfügbarkeit prüfen

Myelodysplastic Syndromes Showing Slight Monocytic Marrow Proliferation Are Prone to Progress to CMML

Leukemia research, 2017-04, Vol.55, p.S79-S79

2017

Link zum Volltext

Verfügbarkeit prüfen

Assessment of an extended dataset of in vitro human dermal absorption studies on pesticides to determine default values, opportunities for read-across and influence of dilution on absorption

Regulatory toxicology and pharmacology, 2015-06, Vol.72 (1), p.58-70

2015

Link zum Volltext

Verfügbarkeit prüfen

P771: PROGNOSTIC CHARACTERISTICS OF PATIENTS WITH MDS WITH ABERRATIONS OF CHROMOSOME 5. DATA FROM THE DÜSSELDORF MDS REGISTRY

HemaSphere, 2022-06, Vol.6, p.666-667

2022

Link zum Volltext

Verfügbarkeit prüfen

W. Otterspeer (ed.), De hand van Huizinga

Bijdragen en mededelingen betreffende de geschiedenis der Nederlanden, 2011-01, Vol.126 (2), p.138-139

Strupp, C.

2011

Link zum Volltext

Verfügbarkeit prüfen

Chronic myelomonocytic leukemia in the light of the WHO proposals

Haematologica (Roma), 2007-07, Vol.92 (7), p.974-977

2007

Link zum Volltext

Verfügbarkeit prüfen

Patients with IPSS-R Intermediate Risk can be Separated Into Three Risk Groups

Leukemia research, 2017-04, Vol.55, p.S147-S147

2017

Link zum Volltext

Verfügbarkeit prüfen

240 DYSPLASIAS REVISITED – CONSIDERATIONS FOR A MULTIDIMENSIONAL APPROACH TO HETEROGENEITY OF MDS: DATA ON 1979 PATIENTS FROM THE GERMAN AUSTRIAN DATA BASE

Leukemia research, 2015-04, Vol.39, p.S119-S119

2015

Link zum Volltext

Verfügbarkeit prüfen

317 ASXL1 MUTATION IS ASSOCIATED TO LOWER PLATELET COUNTS AND DECREASED BONE MARROW CELLULARITY IN MDS

Leukemia research, 2015-04, Vol.39, p.S157-S157

2015

Link zum Volltext

Verfügbarkeit prüfen

Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification

Leukemia, 2007-04, Vol.21 (4), p.678-686

2007

Link zum Volltext

Verfügbarkeit prüfen

Modeling a Thermoelectric HVAC System for Automobiles

Journal of electronic materials, 2009-07, Vol.38 (7), p.1093-1097

2009

Link zum Volltext

Verfügbarkeit prüfen

P-093 Hypoplastic myelodysplastic syndromes are not a specific clinical entity

Leukemia research, 2013-05, Vol.37, p.S63-S63

2013

Link zum Volltext

Verfügbarkeit prüfen

P-255 Inclusion criteria of clinical trials do not meet the real MDS population. A registry-based simulation

Leukemia research, 2013-05, Vol.37, p.S137-S138

2013

Link zum Volltext

Verfügbarkeit prüfen

Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome

Haematologica (Roma), 2011-03, Vol.96 (3), p.441-449

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 334

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(282)
Mit Volltextzugriff
(284)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(159)
Humans
(149)
Life Sciences & Biomedicine
(142)
Female
(106)
Male
(96)
Middle Aged
(78)
Adult
(70)
Biological And Medical Sciences
(70)
Neurosciences & Neurology
(65)
Aged
(64)
Medical Sciences
(60)
Neurosciences
(44)
Clinical Neurology
(42)
Neurology
(35)
Hematology
(33)
Aged, 80 And Over
(32)
Animals
(32)
Hematology, Oncology And Palliative Medicine
(22)
Multidisciplinary Sciences
(21)
Science & Technology - Other Topics
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Leukemia Research
(40)
Annals Of The New York Academy Of Sciences
(18)
Neurology
(10)
Leukemia
(8)
Haematologica
(7)
Journal Of Neurology
(7)
Aktuelle Neurologie
(6)
Annals Of Neurology
(6)
Nervenarzt
(6)
Toxicology Letters
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification

Refined medullary blast and white blood cell count based classification of chronic myelomonocytic leukemias

Assessing in vitro dermal absorption of dry residues of agrochemical sprays using human skin within OECD TG 428

Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid

Who Classification 2016 for the Myelodysplastic Syndromes (MDS): Main Changes

Myelodysplastic syndromes without peripheral monocytosis but with evidence of marrow monocytosis share clinical and molecular characteristics with CMML

Assessment of in vitro human dermal absorption studies on pesticides to determine default values, opportunities for read-across and influence of dilution on absorption

Thalidomide for the treatment of patients with myelodysplastic syndromes

P772: PROGNOSTIC IMPACT OF DISEASE‐RELATED RISK FACTORS AND TREATMENT APPROACHES IN PATIENTS WITH ADVANCED MYELODYSPLASTIC SYNDROMES (MDS)

I-005 WHO 2013

Transfusion Need and Comorbidities are Independent Prognostic Parameters in Low Risk MDS Patients

Refinement of the international prognostic scoring system (IPSS) by including LDH as an additional prognostic variable to improve risk assessment in patients with primary myelodysplastic syndromes (MDS)

Myelodysplastic Syndromes Showing Slight Monocytic Marrow Proliferation Are Prone to Progress to CMML

Assessment of an extended dataset of in vitro human dermal absorption studies on pesticides to determine default values, opportunities for read-across and influence of dilution on absorption

P771: PROGNOSTIC CHARACTERISTICS OF PATIENTS WITH MDS WITH ABERRATIONS OF CHROMOSOME 5. DATA FROM THE DÜSSELDORF MDS REGISTRY

W. Otterspeer (ed.), De hand van Huizinga

Chronic myelomonocytic leukemia in the light of the WHO proposals

Patients with IPSS-R Intermediate Risk can be Separated Into Three Risk Groups

240 DYSPLASIAS REVISITED – CONSIDERATIONS FOR A MULTIDIMENSIONAL APPROACH TO HETEROGENEITY OF MDS: DATA ON 1979 PATIENTS FROM THE GERMAN AUSTRIAN DATA BASE

317 ASXL1 MUTATION IS ASSOCIATED TO LOWER PLATELET COUNTS AND DECREASED BONE MARROW CELLULARITY IN MDS

Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classification

Modeling a Thermoelectric HVAC System for Automobiles

P-093 Hypoplastic myelodysplastic syndromes are not a specific clinical entity

P-255 Inclusion criteria of clinical trials do not meet the real MDS population. A registry-based simulation

Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome

Suchergebnisse filtern